Exposure and risk factors for COVID-19 and the impact of staying home on Michigan residents
暂无分享,去创建一个
John R. Kulka | C. Willer | W. Hornsby | A. Driscoll | C. Brummett | S. Graham | B. Mukherjee | K. Jamerson | N. Sutton | E. Kaleba | S. Hayek | N. Douville | Xu Shi | Kuan-Han H. Wu | Amelia Krause | Bethany Klunder | Ryan Bickett-Hickok | Austin Fellows
[1] J. Roberts,et al. A survey of aortic disease biorepository participants’ preferences for return of research genetic results , 2020, Journal of genetic counseling.
[2] I. Lesser,et al. The Impact of COVID-19 on Women’s Physical Activity Behavior and Mental Well-Being , 2020, International journal of environmental research and public health.
[3] R. Rodríguez-Jiménez,et al. Gender differences in emotional response to the COVID‐19 outbreak in Spain , 2020, Brain and behavior.
[4] S. Galea,et al. Prevalence of Depression Symptoms in US Adults Before and During the COVID-19 Pandemic , 2020, JAMA network open.
[5] D. DeMeo,et al. Sex and gender: modifiers of health, disease, and medicine , 2020, The Lancet.
[6] P. Hegyi,et al. Obesity is a risk factor for developing critical condition in COVID‐19 patients: A systematic review and meta‐analysis , 2020, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[7] Don Bambino Geno Tai,et al. The Disproportionate Impact of COVID-19 on Racial and Ethnic Minorities in the United States , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] S. Kheterpal,et al. Sharing Health Data and Biospecimens with Industry - A Principle-Driven, Practical Approach. , 2020, The New England journal of medicine.
[9] Leora I. Horwitz,et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study , 2020, BMJ.
[10] D. Brodie,et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study , 2020, The Lancet.
[11] George M. Varghese,et al. Clinical management of COVID-19 , 2020, The Indian journal of medical research.
[12] Eun Ji Kim,et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. , 2020, JAMA.
[13] G. Onder,et al. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. , 2020, JAMA.
[14] Yan Wang,et al. Prevalence and predictors of PTSS during COVID-19 outbreak in China hardest-hit areas: Gender differences matter , 2020, Psychiatry Research.
[15] Xin Zhou,et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China , 2020, The Journal of Emergency Medicine.
[16] J. Xiang,et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.
[17] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.
[18] C. Willer,et al. Aortic progression and reintervention in patients with pathogenic variants after a thoracic aortic dissection. , 2020, The Journal of thoracic and cardiovascular surgery.
[19] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[20] Ellen M. Schmidt,et al. Clinical Implications of Identifying Pathogenic Variants in Individuals With Thoracic Aortic Dissection. , 2019, Circulation. Genomic and precision medicine.
[21] Stephanie E. Moser,et al. Association of Polygenic Risk Scores for Multiple Cancers in a Phenome-wide Study: Results from The Michigan Genomics Initiative , 2017, bioRxiv.
[22] Gregory A. Farnum,et al. Protein-altering and regulatory genetic variants near GATA4 implicated in bicuspid aortic valve , 2017, Nature Communications.
[23] K. O’grady,et al. Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients , 2016, Annals of Internal Medicine.
[24] Carmen DeNavas-Walt,et al. Income and Poverty in the United States: 2013 , 2014 .
[25] R. Hays,et al. Content validity of patient-reported outcome measures: perspectives from a PROMIS meeting , 2012, Quality of Life Research.
[26] A. Bauman,et al. Reliability and validity testing of a single-item physical activity measure , 2010, British Journal of Sports Medicine.
[27] F. Wolfe,et al. The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity , 2010, Arthritis care & research.
[28] C. Cleeland,et al. Pain assessment: global use of the Brief Pain Inventory. , 1994, Annals of the Academy of Medicine, Singapore.
[29] M. Brucker. Social Determinants of Health. , 2017, Nursing for women's health.
[30] C Rayner,et al. Informed consent. , 2000, British journal of plastic surgery.